Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows

News News

Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows
TrafficWeatherSports
  • 📰 KSLcom
  • ⏱ Reading Time:
  • 17 sec. here
  • 14 min. at publisher
  • 📊 Quality Score:
  • News: 52%
  • Publisher: 51%

Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes drugs, according to a study published on Friday.

<p>LONDON — Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes&

</p><p>In the study published on Friday in medical journal JAMA Network Open, researchers examined the medical records of 1.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

KSLcom /  🏆 549. in US

Traffic Weather Sports Classifieds Cars Jobs Homes Television Radio Salt Lake Utah Local

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Diabetes patients using Ozempic, other treatments instead of insulin have lower cancer risk, study findsDiabetes patients using Ozempic, other treatments instead of insulin have lower cancer risk, study findsType 2 diabetes patients on GLP-1 treatments, including Ozempic, have a lower risk of 10 types of obesity-related cancers compared to those on insulin, according to a new study.
Read more »

Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefitsBeyond Ozempic: New GLP-1 drugs promise weight loss and health benefitsThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »

Forget Ozempic and Wegovy — Utahns embracing natural solution to boost GLP-1Forget Ozempic and Wegovy — Utahns embracing natural solution to boost GLP-1Given the potential side effects of GLP-1 prescription drugs, many Utahns are seeking alternative methods to naturally boost GLP-1 levels in the body.
Read more »

Non-Diabetic Use Of GLP-1 Drugs Like Ozempic For Weight Loss Affecting Retail Sizing CurvesNon-Diabetic Use Of GLP-1 Drugs Like Ozempic For Weight Loss Affecting Retail Sizing CurvesI've been a journalist for 30 years, as a senior editor at W magazine, and for the last 17 years, covering retail and real estate as a senior editor at WWD. I write about luxury boutiques, independent retailers, department stores, mass chains, and digitally native brands, and the force that's redefining the way we shop – Amazon.
Read more »

Ozempic and Other GLP-1 Drugs May Cut Cancer RiskOzempic and Other GLP-1 Drugs May Cut Cancer RiskNew research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes.
Read more »

Use of weight loss and diabetes drugs like Ozempic has skyrocketed in Mass.Use of weight loss and diabetes drugs like Ozempic has skyrocketed in Mass.Research released by the state's Health Policy commission Thursday showed number of Massachusetts residents prescribed a relatively new class of weight management and diabetes drugs has increased sevenfold over five years. The medications include the brand name drugs Ozempic, Wegovy and Mounjaro.
Read more »



Render Time: 2025-02-12 16:55:23